Insider Shareholders with Direct Ownership of Agios Pharmaceuticals, Inc. (AGIO)
This section provides a comprehensive overview of the insiders with direct ownership of Agios Pharmaceuticals, Inc. (AGIO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
AGIOS PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jacqualyn A Fouse
Director |
146,934 | 56,578 | 140,784 $7.82 Million | 19 |
Jun 13, 2024
Added 2.35%
|
|
David P Schenkein
Director |
299,142 | 277,953 | 126,242 $7.01 Million | 30 |
Jun 13, 2024
Added 2.61%
|
|
Brian Goff
Chief Executive Officer |
147,482 | 68,690 | 78,792 $4.38 Million | 14 |
Aug 08, 2024
Reduced 12.34%
|
|
Sarah Gheuens
Chief Medical Officer |
57,341 | 19,077 | 43,736 $2.43 Million | 26 |
Jul 01, 2024
Reduced 7.81%
|
|
John Maraganore
Director |
3,271 | 3,415 | 30,028 $1.67 Million | 3 |
May 20, 2022
Added 5.01%
|
|
Jonathan Biller
Chief Financial Officer |
23,696 | 7,567 | 22,953 $1.27 Million | 8 |
Feb 22, 2022
Reduced 10.48%
|
|
Cecilia Jones
Chief Financial Officer |
27,705 | 8,876 | 20,158 $1.12 Million | 10 |
Sep 26, 2024
Reduced 11.2%
|
|
Bruce Car
Chief Scientific Officer |
17,415 | 5,510 | 16,752 $930,406 | 8 |
Feb 22, 2022
Reduced 10.86%
|
|
James William Burns
Chief Legal Officer |
50,117 | 43,903 | 15,700 $871,978 | 26 |
Nov 07, 2024
Reduced 34.69%
|
|
Christopher Bowden
Chief Medical Officer |
117,635 | 110,606 | 15,487 $860,147 | 21 |
Jun 18, 2021
Reduced 75.79%
|
|
David Scadden
Director |
11,634 | 0 | 15,483 $859,925 | 4 |
Jun 13, 2024
Added 17.95%
|
|
Maykin Ho
Director |
11,634 | 0 | 14,912 $828,212 | 4 |
Jun 13, 2024
Added 18.51%
|
|
Tsveta Milanova
Chief Commercial Officer |
19,372 | 6,138 | 13,234 $735,016 | 6 |
Jan 24, 2024
Reduced 10.89%
|
|
Richa Poddar
Chief Commercial Officer |
11,348 | 3,542 | 8,508 $472,534 | 9 |
Oct 17, 2022
Reduced 14.86%
|
|
Rahul D. Ballal
Director |
27,992 | 20,000 | 7,992 $443,875 | 7 |
Nov 08, 2024
Reduced 15.8%
|
|
Cynthia Smith
Director |
7,992 | 0 | 7,992 $443,875 | 3 |
Aug 11, 2024
Added 22.36%
|
|
Darrin Miles
Chief Commercial Officer |
10,313 | 9,293 | 7,209 $400,387 | 8 |
May 14, 2021
Reduced 32.44%
|
|
Ian T Clark
Director |
3,271 | 0 | 6,549 $363,731 | 2 |
May 20, 2022
Added 19.49%
|
|
Paul J Clancy
Director |
3,271 | 0 | 6,549 $363,731 | 2 |
May 20, 2022
Added 19.49%
|
|
Kaye I Foster Cheek
Director |
36,634 | 36,764 | 5,348 $297,027 | 11 |
Jun 13, 2024
Reduced 39.99%
|
|
Catherine E. Owen
Director |
1,976 | 0 | 1,976 $109,747 | 1 |
Jun 13, 2024
Added 50.0%
|
|
Jeffrey D Capello
Director |
1,976 | 0 | 1,976 $109,747 | 1 |
Jun 13, 2024
Added 50.0%
|
|
Theodore James Washburn Jr.
Principal Accounting Officer |
11,272 | 13,406 | 813 $45,154 | 25 |
Nov 08, 2024
Reduced 48.71%
|
|
Carman Alenson
Principal Accounting Officer |
4,148 | 4,646 | 0 $0 | 9 |
Jun 21, 2021
Reduced 100.0%
|